PubMed (GeneRIF) for id: 354

Year	Number of Results
1998	1
2001	1
2002	13
2003	12
2004	7
2005	13
2006	18
2007	19
2008	38
2009	34
2010	35
2011	37
2012	28
2013	34
2014	32
2015	18
2016	28
2017	24
2018	14
2019	12
2020	13
2021	12
2022	5
2023	8
2024	1

1

Prostate-specific antigen: An unfamiliar protein in the human salivary glands.

Isola M, Maxia C, Murtas D, Ekström J, Isola R, Loy F. Isola M, et al. J Anat. 2024 May;244(5):873-881. doi: 10.1111/joa.13996. Epub 2023 Dec 18. J Anat. 2024. PMID: 38111134 Free PMC article.

2

RNA-binding protein 14 promotes phase separation to sustain prostate specific antigen expression under androgen deprivation in human prostate cancer.

Tsuji K, Kawata H, Kamiakito T, Nakaya T, Tanaka A. Tsuji K, et al. J Steroid Biochem Mol Biol. 2023 Dec;235:106407. doi: 10.1016/j.jsbmb.2023.106407. Epub 2023 Oct 6. J Steroid Biochem Mol Biol. 2023. PMID: 37806532

3

Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer.

Spyratou V, Freyhult E, Bergh A, Thellenberg-Karlsson C, Wikström P, Welén K, Josefsson A. Spyratou V, et al. Acta Oncol. 2023 Dec;62(12):1698-1706. doi: 10.1080/0284186X.2023.2254480. Epub 2023 Sep 15. Acta Oncol. 2023. PMID: 37713321

4

Association of Kallikrein Related Peptidase 3 (KLK3) gene with dermatophytosis in the UK biobank cohort.

Lehrer S, Rheinstein PH. Lehrer S, et al. Mycoses. 2023 Dec;66(12):1050-1055. doi: 10.1111/myc.13649. Epub 2023 Aug 17. Mycoses. 2023. PMID: 37592324 Free PMC article.

5

The effect of encomir-93 mimic transfection on the expression of miR-93 and PSA and androgen receptor in prostate cancer LNcap cell line.

Mokhtari H, Ebrahimi A, Nejati M, Barartabar Z, Damchi M, Khonakdar-Tarsi A, Zahedi M. Mokhtari H, et al. Horm Mol Biol Clin Investig. 2023 Mar 31;44(3):237-241. doi: 10.1515/hmbci-2022-0096. eCollection 2023 Sep 1. Horm Mol Biol Clin Investig. 2023. PMID: 36995990

6

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death.

Tilki D, Chen MH, Wu J, Huland H, Graefen M, Mohamad O, Cowan JE, Feng FY, Carroll PR, D'Amico AV. Tilki D, et al. J Clin Oncol. 2023 May 1;41(13):2428-2435. doi: 10.1200/JCO.22.02489. Epub 2023 Mar 1. J Clin Oncol. 2023. PMID: 36857638 Free PMC article.

7

[Immuno-analytical characteristics of PSA and derived biomarkers (total PSA, free PSA, p2PSA)].

Desbène C, Boissan M, Loric S, Lamy PJ, Piéroni L. Desbène C, et al. Ann Biol Clin (Paris). 2023 Mar 15;81(1):7-23. doi: 10.1684/abc.2023.1782. Ann Biol Clin (Paris). 2023. PMID: 36757372 Review. French.

8

Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients.

Mahmoud MM, Abdel Hamid FF, Abdelgawad I, Ismail A, Malash I, Ibrahim DM. Mahmoud MM, et al. Asian Pac J Cancer Prev. 2023 Jan 1;24(1):223-229. doi: 10.31557/APJCP.2023.24.1.223. Asian Pac J Cancer Prev. 2023. PMID: 36708571 Free PMC article.

9

Correlation analysis between CD133, Klk3 and grhl2 expression and tumor characteristics in prostate cancer.

Wu J, Guo S, Wang L, Liao Z. Wu J, et al. Cell Mol Biol (Noisy-le-grand). 2022 Feb 27;67(6):68-73. doi: 10.14715/cmb/2021.67.6.10. Cell Mol Biol (Noisy-le-grand). 2022. PMID: 35818212

10

KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression.

Xu J, Shi Z, Wei J, Na R, Resurreccion WK, Wang CH, Sample C, Han M, Zheng SL, Cooney KA, Helfand BT, Isaacs WB. Xu J, et al. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):749-754. doi: 10.1038/s41391-021-00466-6. Epub 2022 Feb 11. Prostate Cancer Prostatic Dis. 2022. PMID: 35149774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

393 results

Results by year